EP1049708A4 - Meth1 and meth2 polynucleotides and polypeptides - Google Patents

Meth1 and meth2 polynucleotides and polypeptides

Info

Publication number
EP1049708A4
EP1049708A4 EP99904190A EP99904190A EP1049708A4 EP 1049708 A4 EP1049708 A4 EP 1049708A4 EP 99904190 A EP99904190 A EP 99904190A EP 99904190 A EP99904190 A EP 99904190A EP 1049708 A4 EP1049708 A4 EP 1049708A4
Authority
EP
European Patent Office
Prior art keywords
meth1
polypeptides
meth2 polynucleotides
meth2
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99904190A
Other languages
German (de)
French (fr)
Other versions
EP1049708A1 (en
Inventor
Luisa Iruela-Arispe
Gregg A Hastings
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Beth Israel Deaconess Medical Center Inc
Original Assignee
Human Genome Sciences Inc
Beth Israel Deaconess Medical Center Inc
Beth Israel Hospital Association
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Beth Israel Deaconess Medical Center Inc, Beth Israel Hospital Association filed Critical Human Genome Sciences Inc
Publication of EP1049708A1 publication Critical patent/EP1049708A1/en
Publication of EP1049708A4 publication Critical patent/EP1049708A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
EP99904190A 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides Withdrawn EP1049708A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7229898P 1998-01-23 1998-01-23
US72298P 1998-01-23
US9853998P 1998-08-28 1998-08-28
US98539P 1998-08-28
PCT/US1999/001313 WO1999037660A1 (en) 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides

Publications (2)

Publication Number Publication Date
EP1049708A1 EP1049708A1 (en) 2000-11-08
EP1049708A4 true EP1049708A4 (en) 2002-09-04

Family

ID=26753215

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99904190A Withdrawn EP1049708A4 (en) 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides

Country Status (9)

Country Link
EP (1) EP1049708A4 (en)
JP (1) JP2002501077A (en)
KR (1) KR20010086224A (en)
CN (1) CN1292796A (en)
AU (1) AU766787B2 (en)
CA (1) CA2319109A1 (en)
MX (1) MXPA00007165A (en)
NZ (1) NZ505855A (en)
WO (1) WO1999037660A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8901198A (en) 1997-08-06 1999-03-01 Millennium Pharmaceuticals, Inc. Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
DE19806581A1 (en) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Ih ion channel sequences and their use
US6649377B1 (en) * 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
JP2003501087A (en) * 1999-06-09 2003-01-14 ジェネンテック・インコーポレーテッド Compositions and methods for treating tumors
US6395889B1 (en) * 1999-09-09 2002-05-28 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding human protease homologs
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
CA2388673A1 (en) * 2000-03-31 2001-10-11 Bayer Corporation Protein having activity as an angiogenesis modulator
JP2002330761A (en) * 2000-04-26 2002-11-19 Pfizer Prod Inc Adamts polypeptide, nucleic acid encoding the same and use thereof
JP2004524003A (en) * 2000-06-29 2004-08-12 コリクサ コーポレイション Compositions and methods for treatment and diagnosis of lung cancer
EP1383922A4 (en) 2001-04-10 2005-03-30 Agensys Inc Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
US8921534B2 (en) 2001-12-12 2014-12-30 Sanofi Pasteur Limited Enhancement of the immune response using CD36-binding domain
JP4484707B2 (en) * 2002-09-27 2010-06-16 昇志 佐藤 Tumor antigen protein and use thereof
WO2010047310A1 (en) 2008-10-20 2010-04-29 大日本住友製薬株式会社 Tumor antigen peptide and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007850A1 (en) * 1997-08-06 1999-02-18 Millennium Biotherapeutics, Inc. Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
EP1004674A1 (en) * 1997-06-03 2000-05-31 Kureha Chemical Industry Co., Ltd. Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004674A1 (en) * 1997-06-03 2000-05-31 Kureha Chemical Industry Co., Ltd. Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein
WO1999007850A1 (en) * 1997-08-06 1999-02-18 Millennium Biotherapeutics, Inc. Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 31 October 1997 (1997-10-31), NCI-CGAP: "National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index", XP002204952, Database accession no. AA635657 *
DATABASE EMBL [online] EBI; 4 February 1997 (1997-02-04), KUNO K.: "Mouse mRNA for secretory protein containing thrombospondin motifs, complete cds", XP002204902, Database accession no. D67076 *
See also references of WO9937660A1 *

Also Published As

Publication number Publication date
WO1999037660A1 (en) 1999-07-29
MXPA00007165A (en) 2002-06-21
AU2464199A (en) 1999-08-09
EP1049708A1 (en) 2000-11-08
AU766787B2 (en) 2003-10-23
NZ505855A (en) 2005-01-28
WO1999037660A9 (en) 1999-10-14
JP2002501077A (en) 2002-01-15
CA2319109A1 (en) 1999-07-29
KR20010086224A (en) 2001-09-10
CN1292796A (en) 2001-04-25

Similar Documents

Publication Publication Date Title
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
IL142122A0 (en) Cyclin d polynucleotides, polypeptides and uses thereof
PT1090128E (en) Modified vitamin-k-dependent polypeptides
EP1142992A4 (en) Polypeptides
ZA9810716B (en) Novel polypeptides
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
IL179047A0 (en) ??-amyloid peptide- binding proteins and polynucleotides encoding the same
GB9806806D0 (en) Peptides and uses thereof
IL136696A0 (en) Sigirr dna and polypeptides
IL153568A (en) Novel polypeptides and polynucleotides
EP1049708A4 (en) Meth1 and meth2 polynucleotides and polypeptides
EP1183344A4 (en) Adam polynucleotides and polypeptides
EP1015474A4 (en) Don-1 gene and polypeptides and uses therefor
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
IL136695A0 (en) V201 dna and polypeptides
GB9726539D0 (en) Polypeptides, polynucleotides and uses thereof
AU4273099A (en) Polypeptides, polynucleotides and uses thereof
EP0939802A4 (en) spsA POLYNUCLEOTIDES AND POLYPEPTIDES
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
EP0998578A4 (en) Sel-10 AND USES THEREOF
GB9821362D0 (en) Polynucleotides and polypeptides
GB9717416D0 (en) Polypeptides,polynucleotides and uses thereof
GB9817303D0 (en) Polypeptides polynucleotides and uses thereof
AU2002227496A8 (en) Polynucleotides and polypeptides
IL136693A0 (en) V196 dna and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000823

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RUBEN, STEVEN, M.

Inventor name: HASTINGS, GREGG, A.

Inventor name: IRUELA-ARISPE, LUISA

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07H 21/04 A, 7C 07K 14/47 B, 7C 12N 15/63 B, 7C 12N 1/21 B, 7C 12N 15/85 B, 7C 12N 9/64 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020718

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060317

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1032596

Country of ref document: HK